1. Van Wyk B.E., Wink M., Rośliny lecznicze świata, 2004.

2. Samochowiec L., Kompendium ziołolecznictwa, wyd. II, 2002.

3. Macku J., Krejca J., Atlas roślin leczniczych, wyd. III, 1989.

4. Lewkowicz-Mosiej T., Leksykon roślin leczniczych, wyd. I, 2003.

5. Frohne D., Leksykon roślin leczniczych, wyd. I, 2010.

6. Lamer – Zarawska E. et al., Fitoterapia i leki roślinne, wyd. I, 2007.

7. Farmakopea Polska III, praca zbiorowa, rok wydania 1954.

8. Bruneton J., Pharmacognosy, phytochemistry, medicinal plants, Paris Lavoisier Publishing, 1995.

9. Hänsel R., Sticher O., Pharmakognosie – Phytopharmazie, Springer Medizin Verlag 2007.

10. Wichtl M. Teedrogen und Phytotherapeutika, Stuttgart, Wissenschaftliche Verlagsgesellschaft, 2002.

11. Hänsel R., Hagers Handbuch der pharmazeutischen Praxis, Drogen E–O, Berlin, Springer wyd 5, 1993.

12. Kolmunzer S., Farmakognozja, PZWL Warszawa, 1998.

13. Leslie G.B., A pharmacometric evaluation of nine BioStrath herbal remedies, Medita, 1978, 8, 31.

14. Reiter M, Brandt W., Relaxant effects on tracheal and ileal smooth muscles of the guinea pig, Arzneimittelforschung, 1985, 35, 408.

15. Gottshall R.Y., Lucas E. H., Lickfeldt A., Roberts J. M., The occurrence of antibacterial substances active against Mycobacterium tuberculosis in seed plants, J. Clinical. Investig., 1949, 28, 920.

16. Recio M. C., Rios J. L., Villar A., Antimicrobial activity of selected plants employed in the Spanish editerranean Area. Part II., Phytother. Res., 1971, 3, 77.

17. Guérin J. C., Réveillere H. P., Activité antifongique d’extraits végétaux a usage thérapeutique Étude de 40 extraits sur 9 souches fongiques, Annales Pharmaceutiques Françaises, 1985, 43, 1.

18. Mahady G.B., Pendland S.L., Stoia A., Hamill F.A. Fabricant D., Dietz B.M., Chadwick L.R., In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother. Res., 2005, 19, 988.

19. Weckessera S., Engela K., Simon-Haarhausa B., Wittmerb A., Pelzb K., Schemppa C.M., Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance, Phytomed, 2007, 14, 508.

20. Böhm K., Untersuchungen über choleretische Wirkungen einiger Arzneipflanzen, Arzneimittelforsch., 1959, 9, 376.

21. Oztürk N., Choleretic activity of Gentiana lutea ssp. symphyandara in rats, Phytomed., 1998, 5, 283.

22. Liu Z.W., Chen C., Jin R., Shi G., Song C., Hu Z., Studies on liver-protecting and bile secretion-promoting effects of gentiopicroside, Zhong Cao Yao, 2002, 33, 47.

23. Kondo Y., Takano F., Hojo H., Suppression of chemically and immunologically induced hepatic injuries by gentiopicroside in mice, Planta Med., 1994, 60, 414.

24. Gebhardt R., Stimulation of acid secretion by extracts of Gentiana lutea L. in cultured cells from rat gastric mucosa, Pharm. Pharmacol. Lett., 1997, 7, 106.

25. Chibanguza G., Marz R., Sterner W., Zur Wirksamkeit und Toxizität eines pflanzlichen Sekretolytikums und seiner Einzeldrogen, Arzneimittelforsch., 1984, 34, 32.

26. Mutschler E., Geisslinger G., Kroemer H.K., Ruth P., Schafer-Korting M., Farmakologia i toksykologia, MedPharm Polska, Wrocław 2010.

27. Akileshwari C., Muthenna P., Nastasijevi B., Joksi G., Petrash J.M., Reddy G.B., Inhibition of aldose reductase by Gentiana lutea extracts, Experimental Diabetes Research, 2012,  Article number147965.

28. Kusar A., Zupancic A., Sentjurc M., Baricevicc D., Free radical scavenging activities of yellow gentian (Gentiana lutea L.) measured by electron spin resonance, Human Exp. Toxicol., 2006, 25, 599.

29. Nastasijevic B., Lazarevic-Pasti T., Dimitrijevic-Brankovic S., Pasti I., Vujacic A., Joksic G., Vasic V., Inhibition of myeloperoxidase and antioxidative activity of Gentiana lutea. Extracts, Journal of Pharmaceutical and Biomedical Analysis, 2012, 66, 191.

30. Nambi V., The use of myeloperoxidase as a risk marker for atherosclerosis, Curr Atheroscler Rep, 2005, 7, 127.

31. Wegner T, Anwendung eines Trockenextraktes aus Gentianae luteae radix bei dyspeptischem Symptomkomplex, Z Phytotherapie, 1997, 19, 163.

32. Borgia M., Sepe N., Borgia R., Ori-bellometti M., Pharmacological activity of a herbs extract: a controlled clinical study, Curr. Ther. Res., 1981, 29, 525.

33. Haraguchi H., Tanaka Y., Kabbash A., Fujioka T., Ishizu T., Yagi A., Monoamine oxidase inhibitors from Gentiana lutea, Phytochem., 2004, 65, 2255.

34. Boyd B., Ongoing progress in Alzheimer’s disease arena,  Drug News Perspect., 2000, 13, 425.

35. Öztürk N., Korkmaz S., Öztürk Y., Başer K.H.C., Effects of gentiopicroside, sweroside and swertiamarine, secoiridoids from Gentian (Gentiana lutea ssp. symphyandra), on cultured chicken embryonic fibroblasts,  Planta Medica, 2006, 72, 289.

36. Mathew A., Taranalli A.D. , Torgal S.S., Evaluation of anti-inflammatory and wound healing activity of Gentiana lutea rhizome extracts in animals, Pharmaceutical Biology, 2004, 42, 8.

37. Leslie G.B., Salmon G., Repeated dose toxicity studies and reproductive studies on nine Bio-Strath herbal remedies, Swiss Med., 1979, 1, 43.

38. WHO monographs on selected medicinal plants, 2007, Vol. 3.